TY  - CONF

T1  - Zoledronic acid provides an enhanced reduction in skeletal-related events in patients with more than three metastatic bone lesions

JO  - CANCER TREATMENT REVIEWS

PY  - 2006/03/01

AU  - Coleman RE

AU  - Chen YM

ED  - 

VL  - 32

SP  - S51

EP  - S51

Y2  - 2025/10/10

ER  -